Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-15
1994-12-13
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548492, 544109, 5142352, C07D20918, C07D41312, A61K 31535, A61K 31405
Patent
active
053730186
ABSTRACT:
The invention relates to the compound of formula (I) ##STR1## wherein A represents an unsubstituted ethenyl group in the trans (E) configuration or a physiologically acceptable salt or metabilically labile ester thereof which are antagonists of excitatory amino acids, to processes for their preparation and to their use in medicine.
REFERENCES:
patent: 3010971 (1961-11-01), Kaiser et al.
patent: 4960786 (1990-10-01), Salituro et al.
patent: 5043334 (1991-08-01), Bell et al.
patent: 5145845 (1992-09-01), Johnson et al.
patent: 5284862 (1994-02-01), Bigge et al.
Salituro et al., J. Med. Chem., 1992, 35, 1791-1799.
Rowley et al., Bioorganic & Medicinal Chemistry Letters, 1992, 2(12), 1627-1630.
Salituro et al., J. Med. Chem., 1990, 33, 2946-2948.
Gray et al., J. Med. Chem., 1991, 34, 1283-1292.
Cugola Alfredo
Gaviraghi Giovanni
Glaxo S.p.A.
Springer David B.
LandOfFree
Indole derivatives and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives and pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1193670